3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Pleural Effusion, Malignant
2
Mesothelioma, Malignant
2
All Solid Tumors
1
Interventions
Pharmaceutical Preparations
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
All Solid Tumors
×
Pharmaceutical Preparations
×
Other solid neoplasm
×
Clear all
NCT01711398
2015-02-12
IP N02
Elro Pharma
Phase 1/2
Completed
15 enrolled